Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy

Abstract excerpt

Within the past decade, there has been a revolution in the types of drugs developed to treat cancer. Therapies that selectively target cancer-specific aberrations, such as kinase inhibitors, have made a dramatic impact on a subset of patients. In spite of these successes, there is still a dearth of treatment options for the vast majority of patients. Therefore, there is a need to design therapies with broader...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related Molecular Pathways
• Share to Protein Degradation and Inhibitors
• Share to Ubiquitin and proteasome pathways